<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The heart has both the greatest caloric needs and the most robust oxidation of fatty acids (FAs) </plain></SENT>
<SENT sid="1" pm="."><plain>Under pathological conditions such as <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, cardiac uptake and oxidation are not balanced and hearts accumulate <z:chebi fb="23" ids="18059">lipid</z:chebi> potentially leading to cardiac lipotoxicity </plain></SENT>
<SENT sid="2" pm="."><plain>We will first review the pathways utilized by the heart to acquire FAs from the circulation and to store <z:chebi fb="0" ids="17855">triglyceride</z:chebi> intracellularly </plain></SENT>
<SENT sid="3" pm="."><plain>Then we will describe mouse models in which excess <z:chebi fb="23" ids="18059">lipid</z:chebi> accumulation causes heart dysfunction and experiments performed to alleviate this toxicity </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, the known relationships between heart <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism and dysfunction in humans will be summarized </plain></SENT>
</text></document>